TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Oct 03, 2025, 3:59 PM
2.12
0.47%
After-hours: Oct 03, 2025, 04:58 PM EDT
-3.21% (1D)
| Bid | 2.08 |
| Market Cap | 119.41M |
| Revenue (ttm) | 6.96M |
| Net Income (ttm) | -136.78M |
| EPS (ttm) | -1.26 |
| PE Ratio (ttm) | -1.67 |
| Forward PE | -1.82 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.26 |
| Volume | 606,178 |
| Avg. Volume (20D) | 318,912 |
| Open | 2.20 |
| Previous Close | 2.18 |
| Day's Range | 2.05 - 2.28 |
| 52-Week Range | 1.02 - 6.22 |
| Beta | 0.99 |
| Ex-Dividend Date | n/a |
About TCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTScan Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
